UTAK Pain Management PM100 (U)

UTAK Pain Management Plus

Lyophilized urine toxicology control for the quantitative determination of Pain Management drugs and their metabolites

100 % human urine matrix

Buprenorphine, Norbuprenorphine, Codeine, Norcodeine, Fentanyl, Norfentanyl, Hydrocodone, Norhydrocodone, Hydromorphone, Meperidine, Normeperidine, Methadone, Methadone Primary Metabolite (EDDP), Morphine, Monoacetylmorphine-6, Oxycodone, Noroxymycodone, Oxymorphone, Noroxymorphone, Tapentadol, N-Desmethyltapentadol, Tramadol, O-Desmethyl-cis-tramadol

Please note: Analyte composition and analyte concentration may vary with each LOT or instrument. Refer to the package insert of currently available lots for specific analyte and stability claims.


  • UTAK REF 91000   PM Plus Low (Pain Management) 5 x 5 ml
    UTAK REF 91002   PM Plus High (Pain Management) 5 x 5 ml  
  • After production:

    30 month at 2…8 °C

    After reconstitution:

    25 days at 2…8 °C

  • Safety data sheet (SDS)


    An actual instruction for use is available under Download. Access to the download area with your login.